Prostate Cancer - Results from #160

Diagnostic performance of high-resolution micro-ultrasound and conventional ultrasound in fusion biopsy for clinically significant prostate cancer detection. March 25, 2025

Does inclusion of neighborhood variables improve clinical risk prediction for advanced prostate cancer in Black and White men? March 25, 2025

Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada. March 25, 2025

Understanding the hospital safety net: Hospital resource limitations impact prostate cancer treatment beyond socioeconomic disparities. March 24, 2025

Small-molecule RNA therapeutics to target prostate cancer. March 24, 2025

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium. March 24, 2025

Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC. March 24, 2025

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. March 24, 2025

FDA Approves New Prostate Cancer Imaging Agent Gozellix® March 21, 2025

Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort. March 21, 2025

Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe. March 21, 2025

A simplified MyProstateScore2.0 for high-grade prostate cancer. March 21, 2025

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. March 21, 2025

Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy. March 21, 2025

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST). March 20, 2025

Risk-stratified Approach to Implementing Population-based Prostate Cancer Screening in Five Pilot Sites in the European Union: A Protocol for the PRAISE-U Project. March 20, 2025

Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients. March 20, 2025

Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. March 20, 2025

Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience. March 20, 2025

Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy. March 20, 2025

Page 9 of 1474